Camlin Fine Sciences Balance Sheet Analysis
Camlin Fine Sciences + Share Capital and Reserves Growth
From March 2020 to March 2024, Camlin Fine Sciences has shown a consistent increase in Share Capital and Total Reserves. Share capital grew from ?12.13 Cr in Mar 2020 to ?16.75 Cr in Mar 2024. Total Reserves escalated significantly from ?364.68 Cr in 2020 to ?698.97 Cr in 2024, indicating a robust accumulation of retained earnings and possibly a healthy reinvestment back into the company.
Camlin Fine Sciences + Debt Management
The company’s borrowings peaked in March 2022 at ?258.27 Cr but notably decreased to ?222.31 Cr by March 2024. This reduction in borrowings suggests an improvement in debt management and a potential decrease in financial risk for the company.
Camlin Fine Sciences + Asset Growth
Camlin Fine Sciences experienced substantial growth in its Net Block, rising dramatically from ?93.57 Cr in March 2020 to ?576.52 Cr in March 2024, primarily reflecting significant capital investments. Current Assets saw growth from ?511.17 Cr to ?858.43 Cr during the same period, highlighting an improvement in liquidity positions.
Other Key Financial Elements
Investments and Loans & Advances have remained relatively stable, providing a balanced financial strategy in its assets distribution.
This data is an analysis for the Standalone Balance Sheet of Camlin Fine Sciences.
Camlin Fine Sciences operates within the chemical sector, which is crucial for investors considering sector-based diversification in their portfolios.